Oncology Therapeutics Network Overview

  • Year Founded
  • 1990

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 200

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 2

Oncology Therapeutics Network General Information

Description

Operator and distributor of oncology drugs and supportive care products to office-based oncology practices. The company distributes medical/surgical supplies in the United States. It operates Lynx2OTN, an Internet portal that offers information on medical product ordering and reimbursement. It provides physicians and their patients with efficient delivery of medications to treat cancer, as well as rheumatoid arthritis, infertility and other chronic conditions requiring the latest intravenous, injectable and oral medicines.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 395 Oyster Point Boulevard
  • Suite 500
  • South San Francisco, CA 94080
  • United States
+1 (800)
Primary Industry
Distributors (Healthcare)
Acquirer
McKesson
Vertical(s)
Corporate Office
  • 395 Oyster Point Boulevard
  • Suite 500
  • South San Francisco, CA 94080
  • United States
+1 (800)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncology Therapeutics Network Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Oncology Therapeutics Network‘s full profile, request access.

Request a free trial

Oncology Therapeutics Network Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncology Therapeutics Network Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Oncology Therapeutics Network‘s full profile, request access.

Request a free trial

Oncology Therapeutics Network Investments (2)

Oncology Therapeutics Network’s most recent deal was a Buyout/LBO with IVPCARE. The deal was made on 09-Apr-2006.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
IVPCARE 09-Apr-2006 Buyout/LBO Pharmaceuticals
Cardinal Health (Oncology Distribution Capabilities) 31-Jan-2006 Buyout/LBO Pharmaceuticals
To view Oncology Therapeutics Network’s complete investments history, request access »

Oncology Therapeutics Network Exits (1)

Oncology Therapeutics Network’s most recent exit was on 09-Apr-2006 from IVPCARE. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
IVPCARE 09-Apr-2006 Completed
  • 2 buyers
To view Oncology Therapeutics Network’s complete exits history, request access »

Oncology Therapeutics Network FAQs

  • When was Oncology Therapeutics Network founded?

    Oncology Therapeutics Network was founded in 1990.

  • Where is Oncology Therapeutics Network headquartered?

    Oncology Therapeutics Network is headquartered in South San Francisco, CA.

  • What is the size of Oncology Therapeutics Network?

    Oncology Therapeutics Network has 200 total employees.

  • What industry is Oncology Therapeutics Network in?

    Oncology Therapeutics Network’s primary industry is Distributors (Healthcare).

  • Is Oncology Therapeutics Network a private or public company?

    Oncology Therapeutics Network is a Private company.

  • What is the current valuation of Oncology Therapeutics Network?

    The current valuation of Oncology Therapeutics Network is .

  • What is Oncology Therapeutics Network’s current revenue?

    The current revenue for Oncology Therapeutics Network is .

  • How much funding has Oncology Therapeutics Network raised over time?

    Oncology Therapeutics Network has raised $300M.

  • Who are Oncology Therapeutics Network’s investors?

    Bristol-Myers Squibb and One Equity Partners have invested in Oncology Therapeutics Network.

  • When was Oncology Therapeutics Network acquired?

    Oncology Therapeutics Network was acquired on 29-Oct-2007.

  • Who acquired Oncology Therapeutics Network?

    Oncology Therapeutics Network was acquired by McKesson.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »